XML 29 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue

4. Revenue

 

We generate revenue primarily through the sales of our licensed products, Ameluz® and BF-RhodoLED® lamps.

 

Related party revenue relates to an arrangement with Biofrontera Bioscience for BF-RhodoLED® leasing and installation service associated with the clinical lamps. This arrangement is no longer effective as of December 31, 2024. Refer to Note 13, Related Party Transactions.